IRL-1620 (VCar-Ly048)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VCar-Ly048 |
|
A potent and specific ligand for the ETB receptor, MW 1820.95.
Datasheet
Specifications
Source
Synthetic
Type
Self-assembling Peptides
Applications
Enhanced delivery and effectiveness of paclitaxel in an animal model of breast cancer
Quantity
200 µg
Purity
> 95%
Antigen Information
Introduction
IRL-1620 can significantly enhance the delivery and effectiveness of paclitaxel in an animal model of breast cancer. It is an essential tool to assess the participation of the endothelin receptor type B (ETB) receptor in some pathophysiological phenomena, by selectively stimulating ETB receptor-mediated responses in various pathophysiological models established in vitro and in vivo.
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
